FEP Blue · Zepbound and Wegovy coverage

Does FEP Blue cover Zepbound or Wegovy?

Last updated

Yes, with prior authorization: federal plans must cover a GLP-1 for weight loss.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Yes, with prior authorization: federal plans must cover a GLP-1 for weight loss. OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. In its words: "Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications." (U.S. Office of Personnel Management, Federal Benefits Open Season Highlights, 2027 Plan Year, opm.gov, read Nov 17, 2026). FEP Blue approves Wegovy injection for chronic weight management in adults with a BMI of 30 or more, or 27 or more with established cardiovascular disease or another weight-related condition, after a comprehensive weight management program. In its words: "a. Age 18+, must have ONE of the following: i. Body mass index (BMI) ≥ 30 kg/m2 ii. Body mass index (BMI) ≥ 27 kg/m2 AND ONE of the following: 1. Patient has established cardiovascular disease" (FEP Blue pharmacy policy 5.99.030 Saxenda Wegovy, effective July 1, 2026, www1.fepblue.org, read Nov 17, 2026). FEP Blue treats Zepbound as a non-preferred option: approval also requires failure of at least two oral weight-loss drugs and a trial of the preferred products unless there is a medical exception. In its words: "2. Inadequate treatment response, intolerance, or contraindication to at least TWO oral medications for weight management (e.g., benzphetamine, diethylpropion, phentermine, Qsymia, etc.)" (FEP Blue (Blue Cross Blue Shield Association) pharmacy policy 5.99.031 Zepbound, effective July 1, 2026, www1.fepblue.org, read Nov 17, 2026).

Questions

FEP Blue, Zepbound and Wegovy: common questions

Does FEP Blue cover Zepbound for weight loss?

Yes, with prior authorization: federal plans must cover a GLP-1 for weight loss. OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. In its words: "Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications." (U.S. Office of Personnel Management, Federal Benefits Open Season Highlights, 2027 Plan Year, opm.gov, read Nov 17, 2026). FEP Blue approves Wegovy injection for chronic weight management in adults with a BMI of 30 or more, or 27 or more with established cardiovascular disease or another weight-related condition, after a comprehensive weight management program. In its words: "a. Age 18+, must have ONE of the following: i. Body mass index (BMI) ≥ 30 kg/m2 ii. Body mass index (BMI) ≥ 27 kg/m2 AND ONE of the following: 1. Patient has established cardiovascular disease" (FEP Blue pharmacy policy 5.99.030 Saxenda Wegovy, effective July 1, 2026, www1.fepblue.org, read Nov 17, 2026). FEP Blue treats Zepbound as a non-preferred option: approval also requires failure of at least two oral weight-loss drugs and a trial of the preferred products unless there is a medical exception. In its words: "2. Inadequate treatment response, intolerance, or contraindication to at least TWO oral medications for weight management (e.g., benzphetamine, diethylpropion, phentermine, Qsymia, etc.)" (FEP Blue (Blue Cross Blue Shield Association) pharmacy policy 5.99.031 Zepbound, effective July 1, 2026, www1.fepblue.org, read Nov 17, 2026). Zepbound not covered: the cash price at your dose

Does FEP Blue cover Wegovy for weight loss?

Yes, with prior authorization: federal plans must cover a GLP-1 for weight loss. OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. In its words: "Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications." (U.S. Office of Personnel Management, Federal Benefits Open Season Highlights, 2027 Plan Year, opm.gov, read Nov 17, 2026). FEP Blue approves Wegovy injection for chronic weight management in adults with a BMI of 30 or more, or 27 or more with established cardiovascular disease or another weight-related condition, after a comprehensive weight management program. In its words: "a. Age 18+, must have ONE of the following: i. Body mass index (BMI) ≥ 30 kg/m2 ii. Body mass index (BMI) ≥ 27 kg/m2 AND ONE of the following: 1. Patient has established cardiovascular disease" (FEP Blue pharmacy policy 5.99.030 Saxenda Wegovy, effective July 1, 2026, www1.fepblue.org, read Nov 17, 2026). FEP Blue treats Zepbound as a non-preferred option: approval also requires failure of at least two oral weight-loss drugs and a trial of the preferred products unless there is a medical exception. In its words: "2. Inadequate treatment response, intolerance, or contraindication to at least TWO oral medications for weight management (e.g., benzphetamine, diethylpropion, phentermine, Qsymia, etc.)" (FEP Blue (Blue Cross Blue Shield Association) pharmacy policy 5.99.031 Zepbound, effective July 1, 2026, www1.fepblue.org, read Nov 17, 2026). Wegovy not covered: the cash price at your dose

Does FEP Blue cover Zepbound for sleep apnea?

FEP Blue's Zepbound policy approves chronic weight management only and calls every other use investigational; it gives no obstructive sleep apnea criteria. In its words: "Zepbound may be considered medically necessary if the conditions indicated below are met. Zepbound may be considered investigational for all other indications." (FEP Blue (Blue Cross Blue Shield Association) pharmacy policy 5.99.031 Zepbound, effective July 1, 2026, www1.fepblue.org, read Nov 17, 2026).

What do Zepbound and Wegovy cost if FEP Blue does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance

Does Medicaid cover Zepbound or Wegovy?

It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.